Intra-Cellular Therapies Up Over 34%, on Track for Record High Close -- Data Talk

Dow Jones
01-13

Intra-Cellular Therapies, Inc. $(ITCI)$ is currently at $127.68, up $32.81 or 34.58%

 

--Would be new all-time high (Based on available data back to Dec. 23, 2013)

--On pace for largest percent increase since Sept. 9, 2020, when it rose 72.87%

--Currently up three of the past four days

--Currently up two consecutive days; up 54.65% over this period

--Best two day stretch since the two days ending Sept. 10, 2020, when it rose 68.37%

--Up 52.87% month-to-date

--Up 52.87% year-to-date

--Up 92.41% from 52 weeks ago (Jan. 12, 2024), when it closed at $66.36

--Would be a new 52-week closing high

--Up 98.35% from its 52-week closing low of $64.37 on March 12, 2024

--Traded as high as $128.00; new all-time intraday high (Based on available data back to Dec. 23, 2013)

--Up 34.92% at today's intraday high; largest intraday percent increase since Sept. 9, 2020, when it rose as much as 83.07%

 

All data as of 10:53:22 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

January 13, 2025 10:55 ET (15:55 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10